Showing results (731-740 of 834) with videos related to

Sort By:
Pageof 84
The Journal of Experimental Medicine|September 29, 2020
Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastomaCatalina Lee-Chang, Jason Miska, David Hou, et al.
The Lancet. Oncology|July 17, 2009
Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trialRoger Stupp, Michael Mayer, Roger Kann, et al.
Journal of the American Chemical Society|November 5, 2014
Lock-arm supramolecular ordering: a molecular construction set for cocrystallizing organic charge transfer complexesAnthea K Blackburn, Andrew C-H Sue, Alexander K Shveyd, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patientsJ Maringwa, C Quinten, M King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2018
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized MicePratiksha Gulati, Julia Rühl, Abhilash Kannan, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2011
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)Gianfranco A Pesce, Dirk Klingbiel, Karin Ribi, et al.
ESMO Open|November 11, 2025
Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14L Frehner, S Schär, S Hayoz, et al.
JCI Insight|December 26, 2024
Endothelial response to blood-brain barrier disruption in the human brainAndrew Gould, Yu Luan, Ye Hou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trialDaniel C Betticher, Shu-Fang Hsu Schmitz, Martin Tötsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastomaRoger Stupp, Monika E Hegi, Bart Neyns, et al.
Pageof 84